|
CCNH expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.515900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.215990E-02 |
| Normal-vs-Stage2 |
3.309800E-01 |
| Normal-vs-Stage3 |
8.201700E-02 |
| Normal-vs-Stage4 |
1.646320E-02 |
| Stage1-vs-Stage2 |
3.245400E-01 |
| Stage1-vs-Stage3 |
5.480600E-01 |
| Stage1-vs-Stage4 |
6.696400E-01 |
| Stage2-vs-Stage3 |
5.848800E-01 |
| Stage2-vs-Stage4 |
2.272800E-01 |
| Stage3-vs-Stage4 |
4.064400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.984100E-02 |
| Normal-vs-AfricanAmerican |
3.363200E-04 |
| Normal-vs-Asian |
4.638000E-02 |
| Caucasian-vs-AfricanAmerican |
1.237830E-02 |
| Caucasian-vs-Asian |
7.924200E-01 |
| AfricanAmerican-vs-Asian |
1.831940E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.988400E-02 |
| Normal-vs-Female |
1.946500E-02 |
| Male-vs-Female |
4.469800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.508380E-02 |
| Normal-vs-Age(41-60Yrs) |
4.609600E-02 |
| Normal-vs-Age(61-80Yrs) |
2.304600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.461450E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.847000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.762750E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.234400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.204600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.512800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.705800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.017200E-01 |
| Classical-VS-Follicular |
1.016430E-01 |
| Classical-VS-Other |
6.350800E-01 |
| Classical-VS-Normal |
2.298200E-03 |
| Tall-VS-Follicular |
5.049800E-01 |
| Tall-VS-Other |
8.890800E-01 |
| Tall-VS-Normal |
1.017830E-01 |
| Follicular-VS-Other |
8.589400E-01 |
| Follicular-VS-Normal |
3.291200E-01 |
| Other-VS-Normal |
4.314400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.573150E-01 |
| Normal-vs-N1 |
5.599700E-02 |
| N0-vs-N1 |
3.886000E-01 |
|
|
